These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18420485)

  • 1. Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice.
    Vlad G; D'Agati VD; Zhang QY; Liu Z; Ho EK; Mohanakumar T; Hardy MA; Cortesini R; Suciu-Foca N
    Diabetes; 2008 Jul; 57(7):1878-86. PubMed ID: 18420485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of antigen-specific human T suppressor cells by membrane and soluble ILT3.
    Vlad G; Suciu-Foca N
    Exp Mol Pathol; 2012 Dec; 93(3):294-301. PubMed ID: 23018130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL6 is required for differentiation of Ig-like transcript 3-Fc-induced CD8+ T suppressor cells.
    Chang CC; Vlad G; D'Agati VD; Liu Z; Zhang QY; Witkowski P; Torkamani AA; Stokes MB; Ho EK; Cortesini R; Suciu-Foca N
    J Immunol; 2010 Nov; 185(10):5714-22. PubMed ID: 20935202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immune system development and rejection of human islet allografts in spontaneously diabetic NOD-Rag1null IL2rgammanull Ins2Akita mice.
    Brehm MA; Bortell R; Diiorio P; Leif J; Laning J; Cuthbert A; Yang C; Herlihy M; Burzenski L; Gott B; Foreman O; Powers AC; Greiner DL; Shultz LD
    Diabetes; 2010 Sep; 59(9):2265-70. PubMed ID: 20570944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
    Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
    Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of galectin-9 in islets prolongs grafts survival via downregulation of Th1 responses.
    Chou FC; Kuo CC; Wang YL; Lin MH; Linju Yen B; Chang DM; Sytwu HK
    Cell Transplant; 2013; 22(11):2135-45. PubMed ID: 23067523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
    Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
    Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the contribution of CD4+ T cells to proislet and islet allograft rejection correlate with constitutive class II MHC alloantigen expression.
    Simeonovic CJ; Brown DJ; Townsend MJ; Wilson JD
    Cell Transplant; 1996; 5(5):525-41. PubMed ID: 8889212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
    Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L
    Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Introduction of Human Heme Oxygenase-1 and Soluble Tumor Necrosis Factor-α Receptor Type I With Human IgG1 Fc in Porcine Islets Prolongs Islet Xenograft Survival in Humanized Mice.
    Lee HS; Lee JG; Yeom HJ; Chung YS; Kang B; Hurh S; Cho B; Park H; Hwang JI; Park JB; Ahn C; Kim SJ; Yang J
    Am J Transplant; 2016 Jan; 16(1):44-57. PubMed ID: 26430779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients.
    Suciu-Foca N; Feirt N; Zhang QY; Vlad G; Liu Z; Lin H; Chang CC; Ho EK; Colovai AI; Kaufman H; D'Agati VD; Thaker HM; Remotti H; Galluzzo S; Cinti P; Rabitti C; Allendorf J; Chabot J; Caricato M; Coppola R; Berloco P; Cortesini R
    J Immunol; 2007 Jun; 178(11):7432-41. PubMed ID: 17513794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane.
    Duvivier-Kali VF; Omer A; Parent RJ; O'Neil JJ; Weir GC
    Diabetes; 2001 Aug; 50(8):1698-705. PubMed ID: 11473027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-LFA-1 improves pig islet xenograft function in diabetic mice when long-term acceptance is induced by CTLA4Ig/anti-CD40L.
    Kumagai-Braesch M; Ekberg H; Wang F; Osterholm C; Ehrnfelt C; Sharma A; Lindeborg E; Holgersson J; Corbascio M
    Transplantation; 2007 May; 83(9):1259-67. PubMed ID: 17496544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular requirements for pancreatic islet xenograft rejection.
    Ahn M; Chang E; Chu G; Barker CF; Markmann JF
    Transplant Proc; 1995 Dec; 27(6):3302-3. PubMed ID: 8539963
    [No Abstract]   [Full Text] [Related]  

  • 18. Pancreatic islet xenograft tolerance after short-term costimulation blockade is associated with increased CD4+ T cell apoptosis but not immune deviation.
    Lehnert AM; Yi S; Burgess JS; O'Connell PJ
    Transplantation; 2000 Mar; 69(6):1176-85. PubMed ID: 10762224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model.
    Wu DC; Hester J; Nadig SN; Zhang W; Trzonkowski P; Gray D; Hughes S; Johnson P; Wood KJ
    Transplantation; 2013 Oct; 96(8):707-16. PubMed ID: 23917725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.